BIASCO, ELISA
 Distribuzione geografica
Continente #
NA - Nord America 556
EU - Europa 193
AS - Asia 96
AF - Africa 19
OC - Oceania 2
Totale 866
Nazione #
US - Stati Uniti d'America 545
SE - Svezia 50
IT - Italia 48
CN - Cina 43
SG - Singapore 32
BG - Bulgaria 26
DE - Germania 25
GB - Regno Unito 24
VN - Vietnam 12
CA - Canada 11
CI - Costa d'Avorio 11
FI - Finlandia 8
SN - Senegal 8
TR - Turchia 6
CH - Svizzera 5
AU - Australia 2
FR - Francia 2
HK - Hong Kong 2
UA - Ucraina 2
IN - India 1
NL - Olanda 1
NO - Norvegia 1
RU - Federazione Russa 1
Totale 866
Città #
Houston 77
Fairfield 72
Woodbridge 53
Chandler 39
Ann Arbor 38
Sofia 26
Ashburn 24
Seattle 23
New York 20
Santa Clara 20
Cambridge 18
Wilmington 16
Dearborn 15
Princeton 14
Serra 13
Abidjan 11
Boardman 10
Frankfurt am Main 10
Lawrence 10
Ottawa 10
Singapore 10
Beijing 9
Lancaster 9
Pisa 9
Dakar 8
Medford 8
Des Moines 7
Florence 7
Nanjing 7
Dong Ket 6
Istanbul 6
Los Angeles 6
London 5
San Diego 5
Fuzhou 4
Grafing 4
Hefei 4
Blackburn 3
Boulder 3
Besencens 2
Bremen 2
Changsha 2
Düsseldorf 2
Guangzhou 2
Hong Kong 2
La Spezia 2
Phoenix 2
Shanghai 2
Canberra 1
Caserta 1
Dallas 1
Geneva 1
Hebei 1
Hounslow 1
Jüchen 1
Kilburn 1
Kunming 1
Lappeenranta 1
Markham 1
Massa 1
Milan 1
Nanchang 1
Netherby 1
Ogden 1
Oslo 1
Positano 1
Redwood City 1
San Francisco 1
Shenyang 1
Shenzhen 1
Utrecht 1
Viareggio 1
Washington 1
Totale 682
Nome #
Feasibility and efficacy of 223Ra-dichloride (223Ra) to treat bone metastases in patients (pts) with castration resistant prostate cancer (mCRPC) 123
Impact of a supportive care service for cancer outpatients: management and reduction of hospitalizations. Preliminary results of an integrated model of care 117
Small-bowel neuroendocrine tumor and retroperitoneal fibrosis: Efficacy of octreotide and tamoxifen 110
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 104
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 94
New Prognostic factors for second-line targeted therapy (TT) in metastatic renal cell carcinoma (mRCC). 93
predictive factors of efficacy of somatostatine analogs (SSA) in gastroenteropancreatic neuroendocrine tumors (GEP-NET) 81
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 61
metastatic well or moderately differentiated Neuroendocrine tumors (WDNET) treated with sequence of different Somatostatin Analogs (SSA) - Lanreotide LAR (La), Octreotide LAR (Oc): a single center experience 59
EARLY AND COMPLETE CLINICAL RESPONSE TO SUNITINIB IN A PATIENT WITH METASTATIC RENAL CANCER 47
Totale 889
Categoria #
all - tutte 2.881
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.881


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 0 0 0 0 15 29 17 10 17 4 5 1
2020/202153 4 1 3 2 4 1 0 3 9 8 2 16
2021/202295 0 5 4 1 19 17 3 2 2 3 5 34
2022/2023153 14 31 17 2 8 17 0 5 43 2 14 0
2023/202490 2 6 18 2 9 23 10 1 1 6 2 10
2024/202556 0 11 0 22 23 0 0 0 0 0 0 0
Totale 889